Ingemar Lagerlöf

5PUBLICATIONS
12CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
The association between inborn errors of immunity and Hodgkin lymphoma-A register-based case-control study in Sweden.

|Jan 25, 2022
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy.

Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad

|Feb 05, 2020
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients.

Lasse H Jakobsen, Fredrik Ellin, Knut B Smeland

|Oct 16, 2019
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.

Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius

Pageof 1

Frequent Collaborators

2 joint publications

Harald Holte

2 joint publications

Ingrid Glimelius

1 joint publications

Lasse H Jakobsen

1 joint publications

Gita Thanarajasingam